Annual CFO:
-$300.87M-$181.81M(-152.70%)Summary
- As of today, RNA annual cash from operations is -$300.87 million, with the most recent change of -$181.81 million (-152.70%) on December 31, 2024.
- During the last 3 years, RNA annual cash from operations has fallen by -$206.06 million (-217.33%).
- RNA annual cash from operations is now -12183.13% below its all-time high of $2.49 million, reached on December 31, 2019.
Performance
RNA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$156.17M+$43.49M(+21.78%)Summary
- As of today, RNA quarterly cash from operations is -$156.17 million, with the most recent change of +$43.49 million (+21.78%) on September 30, 2025.
- Over the past year, RNA quarterly cash from operations has dropped by -$90.56 million (-138.01%).
- RNA quarterly cash from operations is now -1046.45% below its all-time high of $16.50 million, reached on December 31, 2023.
Performance
RNA Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$580.54M-$90.56M(-18.48%)Summary
- As of today, RNA TTM cash from operations is -$580.54 million, with the most recent change of -$90.56 million (-18.48%) on September 30, 2025.
- Over the past year, RNA TTM cash from operations has dropped by -$396.04 million (-214.66%).
- RNA TTM cash from operations is now -4434.32% below its all-time high of $13.39 million, reached on June 30, 2019.
Performance
RNA TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RNA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -152.7% | -138.0% | -214.7% |
| 3Y3 Years | -217.3% | -388.7% | -371.1% |
| 5Y5 Years | -10000.0% | -1613.7% | -2314.5% |
RNA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -217.3% | at low | -1046.5% | +21.8% | -387.6% | at low |
| 5Y | 5-Year | >-9999.0% | at low | -1046.5% | +21.8% | -2314.5% | at low |
| All-Time | All-Time | >-9999.0% | at low | -1046.5% | +21.8% | -4434.3% | at low |
RNA Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$156.17M(+21.8%) | -$580.54M(-18.5%) |
| Jun 2025 | - | -$199.67M(-60.0%) | -$489.98M(-37.9%) |
| Mar 2025 | - | -$124.83M(-25.0%) | -$355.32M(-18.1%) |
| Dec 2024 | -$300.87M(-152.7%) | -$99.87M(-52.2%) | -$300.87M(-63.1%) |
| Sep 2024 | - | -$65.61M(-0.9%) | -$184.50M(-18.5%) |
| Jun 2024 | - | -$65.00M(+7.6%) | -$155.67M(-10.8%) |
| Mar 2024 | - | -$70.38M(-526.5%) | -$140.48M(-18.0%) |
| Dec 2023 | -$119.06M(+12.6%) | $16.50M(+144.9%) | -$119.06M(+31.9%) |
| Sep 2023 | - | -$36.79M(+26.1%) | -$174.75M(-2.8%) |
| Jun 2023 | - | -$49.81M(-1.7%) | -$169.92M(-9.2%) |
| Mar 2023 | - | -$48.97M(-25.0%) | -$155.66M(-14.2%) |
| Dec 2022 | -$136.27M | -$39.19M(-22.6%) | -$136.27M(-10.6%) |
| Sep 2022 | - | -$31.96M(+10.1%) | -$123.22M(-9.9%) |
| Jun 2022 | - | -$35.55M(-20.2%) | -$112.11M(-7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$29.57M(-13.1%) | -$104.71M(-10.4%) |
| Dec 2021 | -$94.81M(-155.4%) | -$26.14M(-25.4%) | -$94.81M(-16.0%) |
| Sep 2021 | - | -$20.84M(+25.9%) | -$81.74M(-16.8%) |
| Jun 2021 | - | -$28.14M(-43.0%) | -$70.01M(-41.5%) |
| Mar 2021 | - | -$19.68M(-50.5%) | -$49.47M(-33.3%) |
| Dec 2020 | -$37.12M(-1590.6%) | -$13.07M(-43.5%) | -$37.12M(-54.4%) |
| Sep 2020 | - | -$9.11M(-19.9%) | -$24.04M(-15.5%) |
| Jun 2020 | - | -$7.60M(-3.6%) | -$20.82M(-1020.2%) |
| Mar 2020 | - | -$7.33M(-24.6%) | $2.26M(-69.9%) |
| Dec 2019 | $2.49M(+125.8%) | - | - |
| Sep 2019 | - | -$5.88M(-138.0%) | $7.51M(-43.9%) |
| Jun 2019 | - | $15.48M(+842.1%) | $13.39M(+742.1%) |
| Mar 2019 | - | -$2.09M | -$2.09M |
| Dec 2018 | -$9.65M | - | - |
FAQ
- What is Avidity Biosciences, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual cash from operations year-on-year change?
- What is Avidity Biosciences, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly cash from operations year-on-year change?
- What is Avidity Biosciences, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. TTM cash from operations year-on-year change?
What is Avidity Biosciences, Inc. annual cash from operations?
The current annual cash from operations of RNA is -$300.87M
What is the all-time high annual cash from operations for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual cash from operations is $2.49M
What is Avidity Biosciences, Inc. annual cash from operations year-on-year change?
Over the past year, RNA annual cash from operations has changed by -$181.81M (-152.70%)
What is Avidity Biosciences, Inc. quarterly cash from operations?
The current quarterly cash from operations of RNA is -$156.17M
What is the all-time high quarterly cash from operations for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly cash from operations is $16.50M
What is Avidity Biosciences, Inc. quarterly cash from operations year-on-year change?
Over the past year, RNA quarterly cash from operations has changed by -$90.56M (-138.01%)
What is Avidity Biosciences, Inc. TTM cash from operations?
The current TTM cash from operations of RNA is -$580.54M
What is the all-time high TTM cash from operations for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high TTM cash from operations is $13.39M
What is Avidity Biosciences, Inc. TTM cash from operations year-on-year change?
Over the past year, RNA TTM cash from operations has changed by -$396.04M (-214.66%)